Clinical Trial Update: A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022

View source ↗

Summary

A completed clinical trial assessing frailty in subjects during ZOSTER-006 and ZOSTER-022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• ZOSTER-006
• ZOSTER-022

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Status: COMPLETED | Results posted: 2020-04-30